XOTIC combines a XOR cipher and One-Time-Pad (OTP) cipher with a Discrete Sequence Generator (a random number generator) to create a quantum-resistant cipher that encrypts and decrypts data in real-time. Compared to standard AES-256 encryption, XOTIC creates a cipher equal in length to the data being encrypted. Additionally, ciphers are subject to brute-force attacks because invalid key attempts immediately report unsuccessful decryption. With XOTIC, any key will report successful decryption – a “false positive” -- but only the correct key will return the correct result thereby greatly reducing the attack surface and making XOTIC quantum computing resistant. Because of the randomness of the XOTIC cipher and the fact that using the wrong key will provide a “false positive” result, it is less likely that a brute force attack would be successful.
XOTIC is covered by US patent number 10,892,889. By exclusively licensing Software Research Labs’ XOTIC patent for Blockchains, Belfrics seeks to be in the forefront of securing blockchain transaction data, protecting and securing their customers’ blockchain information and global transmission of their pertinent data.
The XOTIC cipher was developed and patented by
Regarding the licensing of the XOTIC process by BelfricsBT,
Belfrics CEO and Founder, Praveen Kumar, said, “As a cryptocurrency exchange and blockchain provider, protecting our clients’ assets and data is paramount to our success. Our users expect that we have the most advanced security protecting their data, and with XOTIC we are providing security unavailable on other exchanges and blockchains.”
About Us
For more information on
For more information on Belfrics Global visit www.belfricsgroup.com
For more information on Cognitive Apps Software Solutions visit https://cogapps.com
Forward-Looking Statement Disclaimer
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Forward-looking statements are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements: (i) the initiation, timing, progress and results of the Company’s research, manufacturing and other development efforts; (ii) the Company’s ability to advance its products to successfully complete development and commercialization; (iii) the manufacturing, development, commercialization, and market acceptance of the Company’s products; (iv) the lack of sufficient funding to finance the product development and business operations; (v) competitive companies and technologies within the Company’s industry and introduction of competing products; (vi) the Company’s ability to establish and maintain corporate collaborations; (vii) loss of key management personnel; (viii) the scope of protection the Company is able to establish and maintain for intellectual property rights covering its products and its ability to operate its business without infringing the intellectual property rights of others; (ix) potential failure to comply with applicable health information privacy and security laws and other state and federal privacy and security laws; and (x) the difficulty of predicting actions of the government and its regulations. All forward-looking statements included in this press release are made only as of the date of this press release. The Company assumes no obligation to update any written or oral forward-looking statement unless required by law.
For Media and Investor Relations, please contact:
(866) 692-6847 Toll Free -
(404) 281-8556 Mobile and
dk@atlcp.com
https://www.linkedin.com/in/davidkugelman/
Source:
2022 GlobeNewswire, Inc., source